-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - (aspirin) versus VKA (2 RCTs, one NRCS), LMWH
versus antiplatelet drug (2 NRCSs), antiplatelet drug … versus FXaI (1 RCT), antiplatelet drug versus mechanical
devices (1 RCT, 1 NRCS), antiplatelet drug … drug
and mechanical device; LMWH alone versus combinations
of LMWH and antiplatelet drug, DTI, FXaI … drug, UFH, and mechanical
device. … Across
this study set, 12 classes were evaluated (antiplatelet
drug [aspirin], antiplatelet drug plus
-
effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - (aspirin) versus VKA (2 RCTs, one NRCS), LMWH
versus antiplatelet drug (2 NRCSs), antiplatelet drug … versus FXaI (1 RCT), antiplatelet drug versus mechanical
devices (1 RCT, 1 NRCS), antiplatelet drug … drug
and mechanical device; LMWH alone versus combinations
of LMWH and antiplatelet drug, DTI, FXaI … drug, UFH, and mechanical
device. … Across
this study set, 12 classes were evaluated (antiplatelet
drug [aspirin], antiplatelet drug plus
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - *Including opioid management plans, patient education, urine drug screening, use of prescription drug … The DAWN Report: Highlights of the
2010 Drug Abuse Warning Network (DAWN) Findings on
Drug-Related … Food and Drug Administration. … Food and Drug Administration. … Does
random urine drug testing reduce illicit drug use in
chronic pain patients receiving opioids?
-
effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
May 29, 2025 - So you can look and you can say, OK, what drug are they taking. They're
taking Gabapentin. … amount of additional information about the
utilization of that drug in the real world. … So it limits misattribution of things like nausea if someone's taking a
drug and saying, OK, you know … What's the likelihood that
my nausea today is being caused by this drug? … We had 10 times as many people on drug and 30 times as many controls in our
trial, in observational
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
April 01, 2020 - Harms results are organized by drug
class. … ); NS = nonsteroidal anti-inflammatory drug; nsNSAID =
nonselective nonsteroidal anti-inflammatory drug … Administration warnings, drug
information texts). … Food and Drug Administration website. … Food and Drug Administration
website.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - Few adverse
drug withdrawal events resulted from deprescribing interventions. … Adverse
drug events in ambulatory care. … Reducing Adverse Drug Events in Older
Adults. … Expert Opin Drug Saf.
2021 Jan;20(1):81-91. doi:
10.1080/14740338.2021.1853704. … Drug Ther Bull. 2023
May;61(5):69. doi: 10.1136/dtb.2023.000012. PMID: 36882298.
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update
-
effectivehealthcare.ahrq.gov/products/stent-clopidogrel-practice/research
-
effectivehealthcare.ahrq.gov/products/high-risk-drugs/rapid-research
-
effectivehealthcare.ahrq.gov/products/off-label-use-research-priorities/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
December 20, 2018 - Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review … Drug Therapy for
Early Rheumatoid Arthritis: A Systematic Review Update. … Drug Therapy for
Rheumatoid Arthritis in Adults: An Update. … This should be revised to read the correct drug. … Additionally, drug classes were not
used as part of the search string.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - pain and inflammation and,
ultimately, to slow the progression of joint
Comparative Effectiveness of Drug … For patients with rheumatoid arthritis or
psoriatic arthritis, do drug therapies differ in
their ability … What are the comparative benefits and harms
of drug therapies for rheumatoid arthritis and
psoriatic … The data are limited by the
number of supporting studies for each drug
combination. … The data are limited by the number
of supporting studies for each drug combination.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
January 01, 2008 - ,
gender), other medications, or co-morbidities for which a typical or an atypical
antipsychotic drug
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
August 01, 2007 - Psychotropic drug use in
elderly people with and without dementia. … The quality of antipsychotic drug prescribing in
nursing homes. … Food and Drug Administration. … Available at:
www.fda.gov/cder/drug/advisory/antipsychotics.ht
m. … Paradoxical
relations of drug treatment with mortality in older
persons.
-
effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
October 01, 2007 - ARTICLE
Designed Delays Versus Rigorous Pragmatic Trials
Lower Carat Gold Standards Can Produce Relevant Drug … We simplified the PRT strategy by using designed delays (DD) to
evaluate drug policies. … covering the elderly, the poor, and families with
high drug expenditures, introduced a drug benefit … Periodic letters on evidence-
based drug therapy improves prescribing: a randomized trial. … Randomized controlled trial
of a drug policy change by British Columbia PharmaCare.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
May 01, 2025 - In addition,
drug abstinence, employment, and homelessness were assessed at First Step House only. … Drug Addiction and Periodontal Diseases. … Challenges to Studying Illicit Drug
Users. … Drug Alcohol Rev 2006,
25 (1), 27–37.
https://doi.org/10.1080/09595230500459495
. … $1 OR drug-
associated OR drug-related OR drug-seeking OR ecstasy OR MDMA OR ethanol OR EtOH OR
fentanyl
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - Naltrexone/bupropion combination
drug is an oral, sustained-release drug intended to fight the body's … Food and Drug Administration (FDA). … Pharmaceutical companies struggle
to develop a drug to treat obesity. … Lorcaserin: FDA issues complete response letter
for Lorcaserin new drug application. … FDA accepts new drug application filing for
Qnexa. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - Tufts University
Boston, MA
Katharine Lillie, MD
Center for Drug Evaluation & Research, Food & Drug … Intermediate cardiovascular efficacy outcomes of cardiovascular drug(s) plus supplement versus drug(s … (drug-drug
interactions)
In August 2012, FDA reported an
association between Lovaza and
recurrent … Clinical or intermediate harms with cardiovascular drug(s) plus supplement versus drug(s) plus placebo … Pharmacokinetic outcomes with cardiovascular drug(s) plus supplement versus drug(s) plus placebo, no
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - Available:
http://www.vrtx.com/current-projects/drug-
candidates/vx-770.html. … Vertex's two-drug cystic fibrosis
treatment shows promise. [internet]. … FDA panel backs Vertex cystic-fibrosis
drug Orkambi. Wall Str J. 2015 May 12. … National drug
list: drug list - three (3) tier drug plan. … HealthPartners PreferredRx:
preferred drug list (formulary). [internet].